Azelastine Hydrochloride (Akorn, Inc.)
Welcome to the PulseAid listing for the Azelastine Hydrochloride drug offered from Akorn, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Azelastine Hydrochloride |
SUBSTANCE NAME: | AZELASTINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-11-08 |
END MARKETING DATE: | 0000-00-00 |
Azelastine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Azelastine Hydrochloride from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/mL) |
START MARKETING DATE: | 2016-11-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-718_1251f0af-29a7-4edf-abae-27132ffb24ae |
PRODUCT NDC: | 17478-718 |
APPLICATION NUMBER: | ANDA203660 |
Other AZELASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: